IP Library Granted Patent US 11,229,793
Granted Patent B2
US 11,229,793 · App. 17/159,034 · Granted Jan 25, 2022

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

Inventors: Konstantinos Alataris (Belmont, CA); Andre B. Walker (Monte Sereno, OH); Jon Parker (San Jose, CA); Yougandh Chitre (Santa Clara, CA); Sangsoo Wesley Park (San Jose, CA); James R. Thacker (Homer, AK)
Assignee: Nevro Corp.
A61N1/36071A61N1/0551A61N1/0553A61N1/06A61N1/3616A61N1/36021A61N1/36157A61N1/36164A61N1/36167A61N1/36171A61N1/36175A61N1/36182A61N1/3787A61N1/37235A61N1/37241A61N1/37247A61N1/37264G01R21/133A61N1/3605
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,229,793
App. No.
17/159,034
Granted
Jan 25, 2022
Kind
B2
Abstract

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region to address low back pain without creating unwanted sensory and/or motor side affects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Claims (38)

1. A method for treating a patient, comprising:

programming a signal generator to deliver an electrical signal to the patient's spinal cord via at least one implantable signal delivery device; and

wherein the electrical signal has sequential bi-phasic pulses with a pulse width in a pulse width range from 10 microseconds to 333 microseconds and does not create paresthesia in the patient.

2. The method of claim 1 wherein the pulses form a bi-phasic square wave.

3. The method of claim 1 wherein at least a portion of the signal has a frequency in a frequency range of from 1.5 kHz to 100 kHz.

4. The method of claim 1 wherein at least a portion of the signal has a frequency in a frequency range of from 1.5 kHz to 50 kHz.

5. The method of claim 1 wherein at least a portion of the signal has a frequency in a frequency range of from 3 kHz to 10 kHz.

6. The method of claim 1 wherein at least a portion of the signal has a frequency of 10 kHz.

7. The method of claim 1 wherein the pulse width range is from 25 microseconds to 166 microseconds.

8. The method of claim 1 wherein the pulse width range is from 33 microseconds to 100 microseconds.

9. The method of claim 1 wherein the pulse width range is from 30 microseconds and 35 microseconds.

10. The method of claim 1 wherein at least a portion of the signal has a current amplitude in a range from 0.5 mA to 10 mA.

11. The method of claim 1 wherein the signal generator is implantable in the patient.

12. The method of claim 1 wherein the signal generator is external to the patient.

13. The method of claim 1 wherein programming includes programming the signal generator to deliver the electrical signal to the patient's epidural space.

14. The method of claim 1 wherein programming includes programming the signal generator to deliver the electrical signal to reduce patient pain.

15. A method for treating a patient, comprising:

programming a signal generator to deliver an electrical signal to the patient's spinal cord via at least one implantable signal delivery device; and

wherein the electrical signal has sequential bi-phasic pulses having a pulse width in a pulse width range from 10 microseconds to 333 microseconds and an amplitude that does not create paresthesia in the patient.

16. The method of claim 15 wherein the pulses form a bi-phasic square wave.

17. The method of claim 15 wherein at least a portion of the signal has a frequency in a frequency range of from 1.5 kHz to 100 kHz.

18. The method of claim 15 wherein the pulse width range is from 30 microseconds and 35 microseconds.

19. The method of claim 15 wherein at least a portion of the signal has a current amplitude in a range from 0.5 mA to 10 mA.

20. The method of claim 15 wherein at least a portion of the signal has a current amplitude in a range from 0.5 mA to 4 mA.

21. The method of claim 15 wherein the signal generator is implantable in the patient.

22. The method of claim 15 wherein the signal generator is external to the patient.

23. The method of claim 15 wherein programming includes programming the signal generator to deliver the electrical signal to reduce or eliminate patient pain.

24. The method of claim 23 wherein at least a portion of the signal has a frequency in a frequency range of from 1.5 kHz to 50 kHz.

25. The method of claim 23 wherein the pulse width range is from 30 microseconds and 35 microseconds.

26. The method of claim 23 wherein at least a portion of the signal has a current amplitude in a range from 0.5 mA to 4 mA.

27. A method for treating a patient, comprising:

delivering an electrical signal to the patient's spinal cord via at least one implantable signal delivery device; and

wherein the electrical signal has a sequential bi-phasic pulses with a pulse width in a pulse width range from 10 microseconds to 333 microseconds and does not create paresthesia in the patient.

28. The method of claim 27 wherein delivering the electrical signal includes delivering the electrical signal to a vertebral location within a range from T 9 -T 12 .

29. The method of claim 27 wherein delivering the electrical signal includes delivering the electrical signal to a vertebral location within a range from T 9 -T 10 .

30. A method for treating a patient, comprising:

programming a signal generator to deliver an electrical therapy signal to the patient's spinal cord via at least one implantable signal delivery device; and

wherein the electrical therapy signal has sequential bi-phasic pulses with a pulse width in a pulse width range from 10 microseconds to 333 microseconds and does not create paresthesia in the patient.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2021
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 056993/0783 →
Continuity (7)
Continuation 16537443 · Aug 9, 2019
Continuation 14522500 · Oct 23, 2014
Continuation 14164100 · Jan 24, 2014
Continuation 12765747 · Apr 22, 2010
Provisional Application 61176868 · May 8, 2009
Provisional Application 61171790 · Apr 22, 2009
Related Publication 20210247425A1 · Aug 12, 2021
Cited By (2)
US 12,465,776 US 12,491,365